Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Havlucu (Manisa, Turkey), A. Yorgancioglu (Manisa, Turkey). Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma. 1126

Member's Comments

No comment yet.

Related content which might interest you: Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Evaluation of Asthma control and oral corticosteroids in Severe Asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma Source: International Congress 2018 – Asthma analysis Year: 2018 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Efficacy of Occupational Therapy in patients with COPD Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007 The Efficacy of Bradanicline in Refractory Chronic Cough Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020